Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Blood|May 16, 2023
Structure of coagulation factor VIII bound to a patient-derived anti-C1 domain antibody inhibitorKenneth C Childers, Nathan G Avery, Kevin A Estrada Alamo, et al.
Thrombosis and Haemostasis|December 19, 2014
Epitope mapping via selection of anti-FVIII antibody-specific phage-presented peptide ligands that mimic the antibody binding sitesJoerg Kahle, Aleksander Orlowski, Diana Stichel, et al.
Journal of Thrombosis and Haemostasis : JTH|August 28, 2019
The 3.2 Å structure of a bioengineered variant of blood coagulation factor VIII indicates two conformations of the C2 domainIan W Smith, Anne E d'Aquino, Christopher W Coyle, et al.
Blood|February 2, 2021
Structure of blood coagulation factor VIII in complex with an anti-C1 domain pathogenic antibody inhibitorJoseph S Gish, Lexi Jarvis, Kenneth C Childers, et al.
Blood|January 30, 2024
Conformational activation and inhibition of von Willebrand factor by targeting its autoinhibitory moduleNicholas A Arce, Zoe Markham-Lee, Qian Liang, et al.
Journal of Thrombosis and Haemostasis : JTH|May 4, 2024
Nanobody activator improves sensitivity of the von Willebrand factor activity assay to multimer sizeQian Liang, Ernest T Parker, Gabrielle Dean, et al.
Nature Communications|June 15, 2024
Human gut microbes express functionally distinct endoglycosidases to metabolize the same N-glycan substrateDiego E Sastre, Nazneen Sultana, Marcos V A S Navarro, et al.
Journal of Thrombosis and Haemostasis : JTH|October 30, 2024
Persistent splenic-derived IgMs preferentially recognize factor VIII A2 and C2 domain epitopes but do not alter antibody productionElizabeth S York, Benjamin D Dratch, Jasmine Ito, et al.
Pageof 6